CoChat

Marine Natural Products: A Source of Novel Anticancer Drugs

Open access

The DOI matches its Crossref record; 215 of the 235 references it cites were found in a registry or an index; 37 of the 152 sources its claims cite were checked for support.

Abstract

Cancer remains one of the most lethal diseases worldwide. There is an urgent need for new drugs with novel modes of action and thus considerable research has been conducted for new anticancer drugs from natural sources, especially plants, microbes and marine organisms. Marine populations represent reservoirs of novel bioactive metabolites with diverse groups of chemical structures. This review highlights the impact of marine organisms, with particular emphasis on marine plants, algae, bacteria, actinomycetes, fungi, sponges and soft corals. Anti-cancer effects of marine natural products in in vitro and in vivo studies were first introduced; their activity in the prevention of tumor formation and the related compound-induced apoptosis and cytotoxicities were tackled. The possible molecular mechanisms behind the biological effects are also presented. The review highlights the diversity of marine organisms, novel chemical structures, and chemical property space. Finally, therapeutic strategies and the present use of marine-derived components, its future direction and limitations are discussed.

Overview

CoChat Summary

TL;DR

This review summarizes marine natural products as sources of novel anticancer drugs, covering marine plants, algae, bacteria, actinomycetes, fungi, sponges, and soft corals. It highlights cytotoxic and mechanistic findings, clinical candidates, and chemical property-space diversity, while noting that many marine compounds remain preclinical and the deep sea is largely unexplored.

Key findings

  • Marine-derived compounds show anticancer activity across many tumor cell lines: cryptophycin 1 had IC50 = 0.005 and 0.003 ng/mL against KB and LOVO cells; coibamide A had LC50 < 23 nM against NCIH460 lung and mouse neuro-2a cells; salinosporamide A had IC50 = 0.13, 0.28, 7.5, and 35.0 µM against A-549, HL-60, BEL-7402, and P388 cells, respectively.
  • The review reports 13 natural products isolated from marine organisms being tested in different phases of clinical trials; examples include bryostatin 1 in phase II, ET-743 in phase I, and dolastatin 10 in phase II. Marine-based drugs cited as used against leukemia, metastatic breast cancer, soft tissue sarcoma, and ovarian cancer include cytarabine, eribulin mesylate, brentuximab vedotin, and trabectidine.
  • Marine biodiversity is described as vast: oceans cover over 70% of the earth, nearly 250,000 marine species are described, 99% of all bacteria cannot be cultured, and there are more than 22,000 known microbial secondary metabolites, 70% produced by actinomycetes, 20% by fungi, 7% by Bacillus spp., and 1–2% by other bacteria.
  • ChemGPS-NP analysis using eight principal components based on 35 molecular descriptors showed that the reviewed marine compounds did not form tight clusters, indicating chemical diversity within classes such as marine peptides.

Methods

  • Narrative review of marine natural products with anticancer activity, emphasizing marine plants, algae, bacteria, actinomycetes, fungi, sponges, and soft corals, and covering in vitro, in vivo, and clinical trial reports.
  • For chemical property space, chemical structures were converted to SMILES using Chemsketch and submitted to ChemGPS-NPweb; eight principal component values were obtained from 35 molecular descriptors per compound, and PC1, PC2, and PC3 were plotted in three dimensions.
  • Main analysis is qualitative synthesis of reported cytotoxic activities, mechanisms, and clinical status; no systematic search strategy, inclusion criteria, or quantitative meta-analysis is described.

Limitations

  • Stated in the paper: sampling difficulties and the need for sufficiently large quantities for detailed analyses; less than 5% of the deep sea has been explored and less than 0.01% of the deep-sea floor sampled in detail; preclinical and clinical data for marine natural compound chemoprevention remain scant; NMR is less sensitive than MS and some compound classes cannot be detected by MS; many compounds such as calothrixins A/B, ulithiacyclamide, patellamide, borophycin, and largazole have not yet entered clinical trials; the exact mechanism of sansalvamide A is unknown.
  • Evident from the text: as a narrative review, it lacks a systematic search strategy, formal inclusion/exclusion criteria, risk-of-bias assessment, and quantitative pooling, so the findings are illustrative rather than exhaustive.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/md17090491

Cites

215 of 215 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 (A) Estimated new cancer cases in the worldwide based on Global Cancer (GLOBOCAN)2018. (B) Estimated cancer death in the worldwide based on GLOBOCAN 2018. (C) Estimated number of new cancer cases in different world areas based on GLOBOCAN 2018.
Figure 1 (A) Estimated new cancer cases in the worldwide based on Global Cancer (GLOBOCAN)2018. (B) Estimated cancer death in the worldwide based on GLOBOCAN 2018. (C) Estimated number of new cancer cases in different world areas based on GLOBOCAN 2018.CC BY · PubMed Central
Figure 2 Natural sources for cancer control.
Figure 2 Natural sources for cancer control.CC BY · PubMed Central
Figure 3 Marine drugs and compounds used in clinical trials, its sources and chemical classes.
Figure 3 Marine drugs and compounds used in clinical trials, its sources and chemical classes.CC BY · PubMed Central
Figure 4 Polyphenolic anti-cancer compounds of marine organisms.
Figure 4 Polyphenolic anti-cancer compounds of marine organisms.CC BY · PubMed Central
Figure 5 Polysaccharides of marine organisms against cancer.
Figure 5 Polysaccharides of marine organisms against cancer.CC BY · PubMed Central
Figure 6 Alkaloids from marine organisms for anticancer.
Figure 6 Alkaloids from marine organisms for anticancer.CC BY · PubMed Central
Figure 7 Anticancer peptides from marine organisms.
Figure 7 Anticancer peptides from marine organisms.CC BY · PubMed Central
Figure 8 Clinical compounds and drugs from marine organisms used in cancer treatment.
Figure 8 Clinical compounds and drugs from marine organisms used in cancer treatment.CC BY · PubMed Central
Figure 9 Marine compounds plotted as red, orange, green and blue spheres indicating peptide, polyphenols, polysaccharides and alkaloids respectively. PCs; the red box indicates, PC1, the yellow box indicates, PC2, and the green box indicates, PC3.
Figure 9 Marine compounds plotted as red, orange, green and blue spheres indicating peptide, polyphenols, polysaccharides and alkaloids respectively. PCs; the red box indicates, PC1, the yellow box indicates, PC2, and the green box indicates, PC3.CC BY · PubMed Central

Verification

Claims the paper makes

32 Valid · 3 Not valid · 64 Not checked · 11 Own results and interpretations

69 more claims · 15 with their cited sources checked

Create a free account to see all 110 claims and to verify the 12 references still open.

See all claims — free account
  • It may state two separate claims as one. 23
  • Probably not a substantial claim. 18

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 215 references

Research works printed but not linked: 7

  1. Whitman, 1998, The unseen majority, Proc. Natl. Acad. Sci. USA, 74, 5088
  2. Reyes, 2002, The marine pharmacy: New antitumoral compounds from the sea, Pharm. News, 9, 495
  3. Laatsch, H. (2011). AntiBase 2011: The Natural Compound Identifier, Wiley-Vch.
  4. Harmon, 2000, Ecteinascidin-743 (et-743) induces objective responses and disease control in patients with advanced non-osseous sarcomas: Results from phase Ii trials, Ann. Oncol., 11, 126
  5. Lavakumar, 2012, Anticancer and antioxidant effect of Acanthophora spicifera against EAC induced carcinoma in mice, J. Pharm. Res., 5, 1503
  6. Suja, 2014, Anticancer activity of compounds isolated from marine endophytic fungus Aspergillus terreus, World J. Pharm. Pharm. Sci., 3, 661
  7. Devi, 2015, Molecular modeling, quantitative structure activity relationship and pharmacophore studies on antiǧviral, antiǧmalarial and antiǧinflammatory bioactive compounds from marine sources, Asian J. Pharm. Clin. Res., 8, 36

Cited by

Items 501–551 of 551

Metadata

Authors
Khalifa, S. A. M., Elias, N., Farag, M. A., Chen, L., Saeed, A., Hegazy, M.-E. F., Moustafa, M. S., Abd El-Wahed, A., Al-Mousawi, S. M., Musharraf, S. G., Chang, F.-R., Iwasaki, A., Suenaga, K., Alajlani, M., Göransson, U., & El-Seedi, H. R.
Affiliations
  • Karolinska University Hospital (SE)
  • University of Kalamoon (SY)
  • Cairo University (EG)
  • Fujian Agriculture and Forestry University (CN)
  • Quaid-i-Azam University (PK)
  • Johannes Gutenberg University Mainz (DE)
  • Kuwait University (KW)
  • Department of Chemistry, Faculty of Science, University of Kuwait, 13060 Safat, Kuwait
  • University of Karachi (PK)
  • Kaohsiung Medical University (TW)
  • Keio University (JP)
  • Uppsala University (SE)
  • Jiangsu University (CN)
Corresponding author
El-Seedi, Hesham R.
Venue
Marine Drugs
Publisher
MDPI AG
Published
2019-08-23
Volume
17
Issue
9
Pages
491
ISSN
1660-3397 (ISSN-L)
OpenAlex
W2969876208
Cited by
555
References
235
Citations by year
2026: 32 · 2025: 73 · 2024: 100 · 2023: 88 · 2022: 109 · 2021: 98 · 2020: 49 · 2019: 4
FWCI
6.25
Type
journal article
Language
en
Open access
Locations
  • Marine Drugs (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Uppsala University (Swedish Research links grant 2016-05885 (VR for the years 2017 - 2019))
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
Keywords
marine natural products, anticancer agents, marine organisms, marine algae, marine bacteria, actinomycetes, marine fungi, marine sponges, soft coral, marine plants, apoptosis, cytotoxicity, cancer prevention, molecular mechanisms, bioactive metabolites, anticancer drug discovery
MeSH terms
Animals, Antineoplastic Agents, Biological Products, Clinical Trials as Topic, Disease Models, Animal, Humans, Neoplasms, Treatment Outcome, Aquatic Organisms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.